• Profile
Close

Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease

The Laryngoscope Feb 09, 2018

Tseng WH, et al. - In this study, the efficacy and safety of liquid alginate suspension were evaluated by the authors for treating laryngopharyngeal reflux disease (LPRD). Liquid alginate suspension appeared to be well tolerated. The symptoms and reflux numbers were effectively improved by this suspension but did not demonstrate superiority over placebo. A great placebo effect was present, as observed in the previous studies. Lifestyle modification was found to be significant.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay